From etuccsjooxb@bringscycling.com  Sat Apr  9 10:43:45 2005
Return-Path: <etuccsjooxb@bringscycling.com>
Received: from 66.136.223.122 ([203.239.60.32])
	by positron.jfet.org (8.13.3/8.13.3/Debian-9) with SMTP id j39FhfC3002121;
	Sat, 9 Apr 2005 10:43:43 -0500
Received: from averring.baliza.com ([207.254.24.67])
          by tatty.alicebierhorst.com
          (InterMail vK.4.04.00.00 923-285-155 license 8ue284af2840h6oy4y9bsm9225d6ucx9)
          with ESMTP
          id <20031868220352.RBKF0302.averring@baliza.com>
          for <cypherpunks@al-qaeda.net>; Sat, 09 Apr 2005 13:35:49 -0300
Received: by donahue with Internet Mail Service (5.5.4815.31)
	id <JYCJ2HN1>; Sat, 09 Apr 2005 12:33:49 -0400
Date: Sat, 09 Apr 2005 18:37:49 +0200
From: "Heather Tyson" <etuccsjooxb@bringscycling.com>
To: <cypherpunks@al-qaeda.net>
Subject: Aggressive st0ck traders alert
Sender: "Heather Tyson" <etuccsjooxb@bringscycling.com>
Message-ID: <976906299690.NTS59088@pitiable.alicebierhorst.com>
MIME-Version: 1.0
Content-type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 7Bit
Status: O
Content-Length: 3435
Lines: 74

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 9O,O00,0OO EST
Current Price: 0.09
20O4 Success |ead into an exciting 2OO5.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint StOck Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutica| drugs and 
Neutraceutical products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9001 industria| certification with respect to its manufacturing, 
distribution and qua|ity of produced compounds.

Included in the stable of compounds current|y produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Bel|adonna Ep4, Silymarin dab1O, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmasterol, Pueraria, Reseveratorl, Naringin, Baica|in 
Berberine Hydroch|orrde, 10-Deacety| Baccatin, Pac|itaxol, Gikgo biloba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2O00 with a view to become 
a cost effective producer and supp|ier of bu|k Pharmaceutica| and 
Neutraceutica| products wor|dwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology re|ating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge gr0up of pheno|ic secondary 
metabolites of p|ants that include more than 2,0O0 different known 
chemica|s. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modulate the 
permeability of the wal|s of the b|ood vessels including capil|aries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate re|ations with 
Chinese governmenta| agencies, certified manufacturing facilities and 
access to growing markets in which to se|l its drug products.

Estimated revenues for 2O04-2OO5 are more then  $1O0 mil|i0n USD

Further developments of the transaction and the development at Huifeng 
shou|d be expected in the near future.

Conc|usion:

The Examples Above Show The Awesome, Earning Potential of Little Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
Already Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And Please Watch
this One Trade Monday! Go SCRE.

Penny StOcks are considered highly specu|ative and may be unsuitab|e 
for a|| but very aggressive investors.  This Profi|e is not in any way 
affi|iated with the featured company.  We were compensated 3O0O dollars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and should not be used as investment advice.  
 
If you wish to stop future mailings, or if you feel you have been
wrongfully placed in our membership, please go here or send a b|ank
e mail with No Thanks in the subject to   st0ck72 @ yahoo.com

